Johanna Hynninen
 Adjunct professor, MD, Gynecologic oncologist

Publications

  

  

  

6 of 10

  

  

  

---

• A longitudinal analysis of CA125 glycoforms in the monitoring and follow up of high grade serous ovarian cancer  (2020)  
  • Gynecologic Oncology
   Liina Salminen, Nimrah Nadeem, Shruti Jain, Seija Grènman, Olli Carpén, Sakari Hietanen, Sinikka Oksa, Urpo Lamminmäki, Kim Pettersson, Kamlesh Gidwani, Kaisa Huhtinen, Johanna Hynninen
  (A1 Refereed original research article in a scientific journal)

  
  

• American Association for Cancer Research Special Conference on Advances in Ovarian Cancer Research Sep 13-16, 2019 Atlanta, GA, USA Abstracts  (2020)  
  • Clinical Cancer Research
   Oikkonen J, Sanz NC, Hakkinen A, Li YL, Schulman I, Kivikoski M, Huhtinen K, Hietanen S, Grenman SE, Hynninen J, Lehtonen R, Hautaniemi S
  (Other publication)

  
  

• Analysis of single-cell RNA-seq data from ovarian cancer samples before and after chemotherapy links stress-related transcriptional profile with chemotherapy resistance  (2020)  
  • bioRxiv
   Zhang K, Erkan EP, Dai J, Andersson N, Kaipio K, Lamminen T, Mansuri N, Huhtinen K, Carpen O, Hynninen J, others
  (Other publication)

  
  

• Author Correction: Virtual clinical trials identify effective combination therapies in ovarian cancer  (2020)  
  • Scientific Reports
   Kozłowska E, Vallius T, Hynninen J, Hietanen S, Färkkilä A, Hautaniemi S
  (Other publication)

  
  

• Exploratory Analysis of CA125-MGL and –STn Glycoforms in the Differential Diagnostics of Pelvic Masses  (2020)  
  • The Journal of Applied Laboratory Medicine
   Liina Salminen, Nimrah Nadeem, Anne Lone Rolfsen, Anne Dørum, Teemu D Laajala, Seija Grènman, Sakari Hietanen, Taija Heinosalo, Antti Perheentupa, Matti Poutanen, Nils Bolstad, Olli Carpén, Urpo Lamminmäki, Kim Pettersson, Kamlesh Gidwani, Johanna Hynninen, Kaisa Huhtinen
  (A1 Refereed original research article in a scientific journal)

  
  

• Extracellular matrix proteins increase invasive growth and chemotherapy resistance of ovarian cancer cells  (2020)  
  • Clinical Cancer Research
   Pietila EA, Gonzales-Molina J, Moyano-Galceran L, Lehtinen L, Turunen P, Martins TS, Rantanen V, Hakkinen A, Jamalzadeh S, Zhang KY, Lamminen T, Kaipio K, Hynninen J, Hietanen S, Grenman S, Lehtonen R, Hautaniemi S, Carpen O, Lehti K, Lehti K
  (Other publication)

  
  

• Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125  (2020)  
  • Communications Biology
   Sherif Bayoumy, Heidi Hyytiä, Janne Leivo, Sheikh M. Talha, Kaisa Huhtinen, Matti Poutanen, Johanna Hynninen, Antti Perheentupa, Urpo Lamminmäki, Kamlesh Gidwani & Kim Pettersson
  (A1 Refereed original research article in a scientific journal)

  
  

• HE4 in the evaluation of tumor load and prognostic stratification of high grade serous ovarian carcinoma  (2020)  
  • Acta Oncologica
   Liina Salminen, Kamlesh Gidwani, Seija Grènman, Olli Carpén, Sakari Hietanen, Kim Pettersson, Kaisa Huhtinen, Johanna Hynninen
  (A1 Refereed original research article in a scientific journal)

  
  

• qSNE: quadratic rate t-SNE optimizer with automatic parameter tuning for large datasets  (2020)  
  • Bioinformatics
   Häkkinen A, Koiranen J, Casado J, Kaipio K, Lehtonen O, Petrucci E, Hynninen J, Hietanen S, Carpén O, Pasquini L, Biffoni M, Lehtonen R, Hautaniemi S
  (A1 Refereed original research article in a scientific journal)

  
  

• RNA-seq analysis of high-grade serous ovarian cancer patients before and after chemotherapy reveals chemoresistance-associated genes and pathways  (2020)  
  • Clinical Cancer Research
   Jamalzadeh S, Zhang KY, Hakkinen A, Huhtinen K, Hynninen J, Andersson N, Mansuri N, Carpen O, Erdogan E, Dai J, Vaharautio A, Hietanen S, Oikkonen J, Lehtonen R, Hautaniemi S
  (Other publication)